Pro-Dex Q2 sales up 11% to $18.7M; net income $0.66/share; eyes acquisition of supplier

PRO DEX INC

2026-Q2 EPS reported $2.07 revenue$37,194,000

Net sales $18.7M (+11% YoY) driven by $7.3M in next-gen orthopedic handpiece shipments offset by legacy declines.
Net income $2.2M ($0.66 diluted EPS) vs $2.0M ($0.61) a year ago; gross margin improved to 31%.
Six-month net sales $37.2M (+17%); net income $6.9M includes $6.8M realized gain from Monogram Technologies sale to Zimmer Biomet.
CEO expects near-term acquisition of a local machine shop (current supplier) to add capacity, not immediately accretive.
Three-year contract extension with largest customer provides growth foundation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.